Castle Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +40.6% | -292.4% | – | – | – | -0.8% | |
| – | +3.9% | +10.8% | +31.8% | +621.8% | +209.5% | +16.9% | +29.7% | +154.9% | |
| – | +170.1% | +325.4% | +565.3% | +161.6% | +67.1% | +41.0% | -1.8% | -8.8% | |
| – | – | -208.7% | – | +34.2% | +14.9% | – | – | – | |
| – | – | – | +20,690.9% | -144.8% | – | – | – | – | |
| – | -44.0% | +238.2% | +407.0% | -26.7% | +61.7% | +141.9% | +108.0% | +27.2% | |
| – | -44.0% | +238.2% | +406.7% | +1,303.9% | +149.9% | -90.3% | +209.8% | +20.4% | |
| – | – | – | – | – | -45.8% | – | – | – | |
| – | +3,459.9% | +544.5% | – | – | +116.1% | +204.1% | – | – | |
| – | -78.9% | +286.0% | -230.8% | -100.0% | +1,425.0% | +16.4% | – | -99.2% | |
| – | +78.6% | +457.4% | +246.5% | -98.2% | -72.1% | -251.7% | – | -213.4% | |
| – | – | +2,788.9% | +229.6% | -125.8% | – | – | – | -114.3% | |
| – | – | – | -15.9% | -539.3% | – | – | – | -22.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.